Home/Resources/Singapores Gcmd Completes Final Biofuel Trial With Hapag Lloyd And Bp

Singapore’s GCMD completes final biofuel trial with Hapag-Lloyd and BP

Exploring how smart logistics and multimodal routes connect landlocked nations to global trade.

News

July 31, 2024

Singapore’s Global Centre for Maritime Decarbonisation (GCMD) has successfully concluded its final biofuel trial in collaboration with German container firm Hapag-Lloyd and energy giant BP.

This marks the fifth and final trial in an $18 million project initiated by GCMD in 2022, aimed at testing various biofuel blends to reduce carbon emissions in maritime shipping.

During this latest trial, BP supplied 4,500 metric tons of a B30 biofuel blend to a Hapag-Lloyd container vessel at Rotterdam port. The blend comprised 30% neat fatty acid methyl esters (FAME) and 70% very low sulphur fuel oil (VLSFO), resulting in a 27.9% reduction in emissions compared to conventional VLSFO.

Additionally, tracing technology was employed to verify the biofuel's origin and composition. Based on the trials' findings, GCMD will release a framework for marine biofuels in the fourth quarter of this year.

GCMD continues engaging in other marine biofuel projects, including collaborating with Japanese shipping major NYK Line.